Manufacturing facility
Naari Pharma Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No.: 14-16, 55-57, Sector-5, IIE, Pantnagar, Dist. Udham Singh Nagar, Rudrapur, Uttarakhand 263153, India (IND)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3014247908 · DUNS 915787058
Drugs this plant is listed as making
9 distinct drugs across 14 products name this site in their FDA label.
- desogestrel and ethinyl estradiolNaari Pte Limited
- desogestrel and ethinyl estradiol and ethinyl estradiolNaari Pte. Limited
- estradiol and norethindrone acetateNaari Pte. Limited
- Levonorgestrel and Ethinyl EstradiolNaari Pte Limited
- MifepristoneEvita Solutions LLC
- NorethindroneNaari Pte. Limited
- Norethindrone and ethinyl estradiolNaari Pte Limited
- norethindrone and ethinyl estradiol and ferrous fumarate tabletNaari Pte Limited
- Norgestimate and ethinyl estradiolNaari Pte Limited
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.